The Norwegian Healthcare Investigation Board (NHIB) determined that the country’s existing model of cross-sex treatments for minors is not evidence-based and is moving to heavily restrict the practice, according to a report the agency released Thursday.
NHIB recommended that puberty blockers, cross-sex hormones and surgeries for children with gender dysphoria be classified as experimental treatments and called for the creation of a national registry to track the quality of care for gender dysphoria treatment, according to an English translation of the report. The surge in adolescents seeking cross-sex medical treatment, particularly among females, raised concerns for public health authorities about the affirming model, in which medical professionals accept patients’ transgender identification and and help them transition to the opposite sex with minimal gatekeeping.
The Daily Caller was founded in 2010 by Tucker Carlson, a 20-year veteran journalist, and Neil Patel, former chief policy advisor to Vice President Cheney, The Daily Caller is one of America’s largest and fastest-growing news publications. Our team of experienced, full-time reporters and editors works around the clock to deliver award-winning original reporting, in-depth investigations, entertainment, thought-provoking commentary and up-to-the-second breaking news. Visit https://dailycaller.com